{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:55:22Z","timestamp":1777294522941,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Examine 11-year trends in opioid and sedative exposure and dosing practices in a level IV neonatal intensive care unit (NICU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included NICU admissions from 2014 to 2024 that received at least one opioid or sedative. Temporal changes in patient characteristics, exposure patterns, continuous infusion regimen composition, and morphine and dexmedetomidine infusion rates were evaluated across three epochs (2014-2017, 2018-2021, 2022-2024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 2055 admissions, 1060 (51.6%) encounters were analyzed. Infants admitted in later years were more premature with greater morbidity. Dexmedetomidine continuous infusion use increased fivefold (7.9% to 44.1%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), while morphine infusion use also increased (36.7% to 50.4%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0021). Morphine plus dexmedetomidine became the most common continuous infusion regimen by 2022-2024 (28.7%), with higher infusion rates in combination therapy than in monotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NICU sedation strategies shifted from morphine monotherapy toward combination therapy with dexmedetomidine. Standardized, outcome-oriented guidelines and multicenter studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41372-026-02586-0","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T09:59:54Z","timestamp":1771840794000},"page":"605-611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analgesia and sedation trends in a level IV NICU, 2014\u20132024: Opioid and dexmedetomidine use"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0070-0798","authenticated-orcid":false,"given":"Sin Yin","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5615-5613","authenticated-orcid":false,"given":"Abrar","family":"Majeedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-1698","authenticated-orcid":false,"given":"Ryan M.","family":"McAdams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"2586_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2024.151928","volume":"48","author":"T Selvanathan","year":"2024","unstructured":"Selvanathan T, Miller SP. Effects of pain, sedation and analgesia on neonatal brain injury and brain development. Semin Perinatol. 2024;48:151928.","journal-title":"Semin Perinatol"},{"key":"2586_CR2","unstructured":"Committee on Fetus and Newborn, Section on Anesthesiology and Pain Medicine. Prevention and Management of Procedural Pain in the Neonate: An Update. Pediatrics 2016;137:e20154271."},{"key":"2586_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jama.300.1.60","volume":"300","author":"R Carbajal","year":"2008","unstructured":"Carbajal R, Rousset A, Danan C, Coquery S, Nolent P, Ducrocq S, et al. Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA. 2008;300:60\u201370.","journal-title":"JAMA"},{"key":"2586_CR4","doi-asserted-by":"publisher","first-page":"F448","DOI":"10.1136\/adc.2005.082263","volume":"91","author":"KJ Anand","year":"2006","unstructured":"Anand KJ, Hall RW. Pharmacological therapy for analgesia and sedation in the newborn. Arch Dis Child Fetal Neonatal Ed. 2006;91:F448\u2013453.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2586_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clp.2008.09.007","volume":"36","author":"RW Hall","year":"2009","unstructured":"Hall RW, Shbarou RM. Drugs of choice for sedation and analgesia in the neonatal ICU. Clin Perinatol. 2009;36:15\u201326.","journal-title":"Clin Perinatol"},{"key":"2586_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJM198711193172105","volume":"317","author":"KJ Anand","year":"1987","unstructured":"Anand KJ, Hickey PR. Pain and its effects in the human neonate and fetus. N Engl J Med. 1987;317:1321\u20139.","journal-title":"N Engl J Med"},{"key":"2586_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00002508-199603000-00004","volume":"12","author":"B Stevens","year":"1996","unstructured":"Stevens B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile: development and initial validation. Clin J Pain. 1996;12:13\u201322.","journal-title":"Clin J Pain"},{"key":"2586_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00431-025-06074-z","volume":"184","author":"C Arribas","year":"2025","unstructured":"Arribas C, Cavallaro G, Decembrino N, Gonz\u00e1lez JL, Lagares C, Raffaeli G, et al. A global cross-sectional survey on neonatal analgosedation: unveiling global trends and challenges through latent class analysis. Eur J Pediatr. 2025;184:241.","journal-title":"Eur J Pediatr"},{"key":"2586_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpeds.2013.10.002","volume":"164","author":"C Chrysostomou","year":"2014","unstructured":"Chrysostomou C, Schulman SR, Herrera Castellanos M, Cofer BE, Mitra S, da Rocha MG, et al. A phase II\/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr. 2014;164:276\u2013.e271-3.","journal-title":"J Pediatr"},{"key":"2586_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1517\/17425255.4.5.619","volume":"4","author":"C Chrysostomou","year":"2008","unstructured":"Chrysostomou C, Schmitt CG. Dexmedetomidine: sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol. 2008;4:619\u201327.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2586_CR11","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/PCC.0000000000000200","volume":"15","author":"LD Whalen","year":"2014","unstructured":"Whalen LD, Di Gennaro JL, Irby GA, Yanay O, Zimmerman JJ. Long-term dexmedetomidine use and safety profile among critically ill children and neonates. Pediatr Crit Care Med. 2014;15:706\u201314.","journal-title":"Pediatr Crit Care Med"},{"key":"2586_CR12","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1097\/pq9.0000000000000106","volume":"3","author":"TD Puthoff","year":"2018","unstructured":"Puthoff TD, Shah H, Slaughter JL, Bapat R. Reduction of Analgesia Duration after Tracheostomy during Neonatal Intensive Care: A Quality Initiative. Pediatr Qual Saf. 2018;3:e106.","journal-title":"Pediatr Qual Saf"},{"key":"2586_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/01.PCC.0000257100.31779.41","volume":"8","author":"JD Tobias","year":"2007","unstructured":"Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8:115\u201331.","journal-title":"Pediatr Crit Care Med"},{"key":"2586_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1213\/ANE.0b013e31822b8629","volume":"113","author":"KP Mason","year":"2011","unstructured":"Mason KP, Lerman J. Review article: Dexmedetomidine in children: current knowledge and future applications. Anesth Analg. 2011;113:1129\u201342.","journal-title":"Anesth Analg"},{"key":"2586_CR15","first-page":"Cd011107","volume":"2015","author":"SR Lewis","year":"2015","unstructured":"Lewis SR, Nicholson A, Smith AF, Alderson P. Alpha-2 adrenergic agonists for the prevention of shivering following general anaesthesia. Cochrane Database Syst Rev. 2015;2015:Cd011107.","journal-title":"Cochrane Database Syst Rev"},{"key":"2586_CR16","first-page":"2022","volume":"ume 13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zhou H, Zhang H, Sui Y, Zhang Z, Zou Y, et al. The neuroprotective effect of dexmedetomidine and its mechanism. Front Pharmacol. 2022;ume 13:2022.","journal-title":"Front Pharmacol"},{"key":"2586_CR17","volume":"2020","author":"RM McAdams","year":"2020","unstructured":"McAdams RM, Pak D, Lalovic B, Phillips B, Shen DD. Dexmedetomidine Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia. Anesthesiol Res Pract. 2020;2020:2582965.","journal-title":"Anesthesiol Res Pract"},{"key":"2586_CR18","doi-asserted-by":"publisher","first-page":"e2341033","DOI":"10.1001\/jamanetworkopen.2023.41033","volume":"6","author":"S Curtis","year":"2023","unstructured":"Curtis S, Kilpatrick R, Billimoria ZC, Zimmerman K, Tolia V, Clark R, et al. Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants. JAMA Netw Open. 2023;6:e2341033.","journal-title":"JAMA Netw Open"},{"key":"2586_CR19","volume":"17","author":"E Cicalese","year":"2025","unstructured":"Cicalese E, Shah A, Bashqoy F, Pierce K, Howell H, Desai P. Analysis of the Impact of Dexmedetomidine Use in Very Preterm Infants on Long-Term Neurodevelopmental Outcomes. Cureus. 2025;17:e86005.","journal-title":"Cureus"},{"key":"2586_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/pne2.12130","volume":"6","author":"C Irving","year":"2024","unstructured":"Irving C, Durrmeyer X, Decobert F, Dassieu G, Ben Guirat A, Gouyon B, et al. Use of dexmedetomidine during mechanical ventilation in extremely preterm and extremely low birth weight neonates receiving morphine: A single-center retrospective study. Paediatr Neonatal Pain. 2024;6:194\u2013202.","journal-title":"Paediatr Neonatal Pain"},{"key":"2586_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41372-020-00878-7","volume":"41","author":"C McPherson","year":"2021","unstructured":"McPherson C, Ortinau CM, Vesoulis Z. Practical approaches to sedation and analgesia in the newborn. J Perinatol. 2021;41:383\u201395.","journal-title":"J Perinatol"},{"key":"2586_CR22","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1542\/peds.2009-0489","volume":"125","author":"KJS Anand","year":"2010","unstructured":"Anand KJS, Willson DF, Berger J, Harrison R, Meert KL, Zimmerman J, et al. Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill Children. Pediatrics. 2010;125:e1208\u201325.","journal-title":"Pediatrics"},{"key":"2586_CR23","first-page":"Cd002052","volume":"1","author":"E Ng","year":"2017","unstructured":"Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Rev. 2017;1:Cd002052.","journal-title":"Cochrane Database Syst Rev"},{"key":"2586_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/archpedi.153.4.331","volume":"153","author":"KJ Anand","year":"1999","unstructured":"Anand KJ, Barton BA, McIntosh N, Lagercrantz H, Pelausa E, Young TE, et al. Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial Neonatal Outcome and Prolonged Analgesia in Neonates. Arch Pediatr Adolesc Med. 1999;153:331\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2586_CR25","doi-asserted-by":"crossref","unstructured":"Morton SU, Labrecque M, Moline M, Hansen A, Leeman K. Reducing Benzodiazepine Exposure by Instituting a Guideline for Dexmedetomidine Usage in the NICU. Pediatrics 2021;148:e2020041566.","DOI":"10.1542\/peds.2020-041566"},{"key":"2586_CR26","doi-asserted-by":"publisher","first-page":"e2115998","DOI":"10.1001\/jamanetworkopen.2021.15998","volume":"4","author":"M Puia-Dumitrescu","year":"2021","unstructured":"Puia-Dumitrescu M, Comstock BA, Li S, Heagerty PJ, Perez KM, Law JB, et al. Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines. JAMA Netw Open. 2021;4:e2115998.","journal-title":"JAMA Netw Open"},{"key":"2586_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jama.2012.148050","volume":"309","author":"I Ceelie","year":"2013","unstructured":"Ceelie I, de Wildt SN, van Dijk M, van den Berg MMJ, van den Bosch GE, Duivenvoorden HJ, et al. Effect of Intravenous Paracetamol on Postoperative Morphine Requirements in Neonates and Infants Undergoing Major Noncardiac Surgery: A Randomized Controlled Trial. JAMA. 2013;309:149\u201354.","journal-title":"JAMA"},{"key":"2586_CR28","doi-asserted-by":"publisher","first-page":"e2138420","DOI":"10.1001\/jamanetworkopen.2021.38420","volume":"4","author":"AK Patel","year":"2021","unstructured":"Patel AK, Gai J, Trujillo-Rivera E, Faruqe F, Kim D, Bost JE, et al. Association of Intravenous Acetaminophen Administration With the Duration of Intravenous Opioid Use Among Hospitalized Pediatric Patients. JAMA Network Open. 2021;4:e2138420.","journal-title":"JAMA Network Open"},{"key":"2586_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMra1800222","volume":"380","author":"JAJ Martyn","year":"2019","unstructured":"Martyn JAJ, Mao J, Bittner EA. Opioid Tolerance in Critical Illness. N Engl J Med. 2019;380:365\u201378.","journal-title":"N Engl J Med"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02586-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:51:50Z","timestamp":1777290710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02586-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2586"],"URL":"https:\/\/doi.org\/10.1038\/s41372-026-02586-0","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr McAdams reports receiving personal fees as a consultant for General Electric HealthCare, outside the submitted work. The authors otherwise have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"COMPETING INTERESTS"}},{"value":"The study was approved by the institutional review board at the University of Wisconsin-Madison, Madison, WI, with a waiver of informed consent. The study was performed in accordance with the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}